Studies have shown that VEGF-C overexpression multiplied tumor lymphangiogenesis and lymph node metastasis in orthotopic models of CRC, which could be blocked by VEGFR3-blocking antibodies (82, 83). This evidence concerns the gene FLT4 and neoplasm.